Cargando…
Multi-vessel Versus Culprit-vessel-only PCI for STEMI: Where Does the Jury Stand?
Autores principales: | Almas, Talal, Akram, Ayesha, Ehtesham, Maryam, Ahmed, Reema, Khedro, Tarek, Malik, Uzair, Alshaikh, Lamees, Alshaikh, Lina, Sattar, Yasar, Hassan Virk, Hafeez Ul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100091/ https://www.ncbi.nlm.nih.gov/pubmed/33996070 http://dx.doi.org/10.1016/j.amsu.2021.102343 |
Ejemplares similares
-
COVID-19-induced takotsubo cardiomyopathy: Venturing beyond the obvious
por: Almas, Talal, et al.
Publicado: (2021) -
The travails of therapeutic modifications in cancer care amidst the COVID-19 pandemic: Future directions and lessons learned
por: Almas, Talal, et al.
Publicado: (2021) -
Prognosis of STEMI Patients with Multi-Vessel Disease Undergoing Culprit-Only PCI without Significant Residual Ischemia on Non-Invasive Stress Testing
por: Weissler-Snir, Adaya, et al.
Publicado: (2015) -
Prasugrel versus ticagrelor for acute coronary syndrome patients undergoing percutaneous coronary intervention: A critical appraisal of randomized controlled trials
por: Almas, Talal, et al.
Publicado: (2022) -
Complete versus culprit-vessel only revascularization in STEMI: An updated meta-analysis of randomized control trials
por: Gupta, Kartik, et al.
Publicado: (2020)